JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH
5
(
Tetramethylsilane) as an internal reference (Bruker Company, Massachusetts, USA).
HRESIMS data were obtained on an Agilent 7890–7000A mass spectrometer (Agilent
Technologies, Santa Clara, USA). Preparative HPLC (high-performance liquid chroma-
tography) was conducted with an Angilent Technologies 1200 series instrument with a
MWD detector using a YMC-pack ODS (Octadecylsilyl)-A column (5 μm, 250 × 20 mm).
Column chromatography was performed with silica gel (200–300 mesh, Qingdao Haiyang
Chemical Ltd., Qingdao, China), Develosil ODS (50 μm, Nomura Chemical Co. Ltd., Osaka,
Japan), Sephadex LH-20 (GE Healthcare Bio-Sciences AB, Uppsala, Sweden). TLC (thin
layer chromatography) was carried out with glass precoated with silica gel GF . Spots
2
54
were visualized under UV light or by spraying with 10% sulfuric acid in EtOH followed by
heating. WB-F344 cells come from the Institute of Materia Medica, Chinese Academy of
Medical Sciences, Beijing.
3
.2. Plant material
e leaves of Callicarpa nudiflora Hook were collected from Wuzhishan, Hainan, China and
identified by Prof. Guiping Yuan at Jiangxi Provincial Institute for Drug and Food Control,
China. A voucher specimen (No. 20110817) has been deposited in the Herbarium of Jiangxi
Provincial Institute for Drug and Food Control.
3
.3. Extraction and isolation
e powdered dried leaves of Callicarpa nudiflora (9.6 kg) were extracted with 80% EtOH
at reflux for 3 × 2 h, and the extract was evaporated under reduced pressure to yield a
dark brown residue (1.8 kg), which was suspended in water (15 L) and then partitioned
with petroleum ether (3 × 15 L), EtOAc (3 × 15 L), and n-BuOH (3 × 15 L), successively.
Af er removing the solvent, the n-BuOH extract (545 g) was passed through a XAD-7
macroporous resin column eluted with H O and H O-EtOH (5:95, v/v), respectively. e
2
2
H O-EtOH (5:95, v/v) fraction (236 g) was separated by silica gel column chromatography
2
(
CC), eluting with CHCl -MeOH gradient mixtures (99:1−60:40, v/v), to afford 13 fractions,
3
E1–E13. Fraction E6 (23.9 g) was fractionated via silica gel CC, eluting with CHCl -MeOH
3
(
85:15−75:25, v/v) to give five fractions (E6-1−E6-5). Fraction E6-4 (7.18 g) was again
subjected to silica gel CC and eluted with CHCl -MeOH (95:5−80:20, v/v) to afford 12
3
fractions (E6-4-1−E6-4-12). Fraction E6–4-10 (4.31 g) was separated by ODS CC (30−100%,
MeOH−H O) to give 17 subfractions. Subfraction 9 (457 mg) was further separated by
2
preparative HPLC (YMC-ODS-A 5 μm, 250 mm × 20 mm, detection at 210 nm) using
1
1
9% CH CN-H O (5 ml/min) containing 0.01%TFA as mobile phase to yield compounds
3 2
(14.0 mg, t 84 min) and 2 (47.4 mg, t 93 min). Subfraction 12 (457 mg) was purified
R R
further by preparative HPLC (YMC-ODS-A 5 μm, 250 mm × 20 mm, detection at 210 nm)
using 16% CH CN-H O (7 ml/min) as mobile phase to yield compounds 3 (7.0 mg, t
3
2
R
1
21 min), 4 (12.6 mg, t 133 min) and 5 (6.7 mg, t 148 min).
R
R
3
.3.1. Callicoside C (1)
2
0
White amorphous powder;[ꢀ] − 58.8(c 0.08, MeOH); UV (MeOH) λ (logε): 228 (4.72)
D
max
1
13
and 312 (4.38) nm; H NMR (600 MHz, CD OD) and C NMR (150 MHz, CD OD) spec-
tral data see Table 1; HRESIMS: m/z 521.1656 [M – H] (calcd for C H O , 521.1659).
3
3
–
2
5
29 12